N. Hanna

Brian C. Case, M. Buchbinder, L. Satler, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Anatomical characteristics associated with hypoattenuated leaflet thickening in low-risk patients undergoing transcatheter aortic valve replacement.

M. Buchbinder, H. Garcia-Garcia, T. Bilfinger, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Coronary Artery Disease Assessed by Computed Tomography-Based Leaman Score in Patients With Low-Risk Transcatheter Aortic Valve Implantation.

M. Buchbinder, H. Garcia-Garcia, T. Bilfinger, 2020, The American journal of cardiology.

Subclinical leaflet thrombosis and antithrombotic therapy post-TAVI: An LRT substudy.

M. Buchbinder, L. Satler, F. Asch, 2022, International journal of cardiology.

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Christopher M. Horvat, David T. Huang, R. Hyzy, 2021, The New England journal of medicine.

The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping β-Carotene and Retinol SupplementsGoodman GE, Thornquist MD, Balmes J, et al (Fred Hutchinson Cancer Research Ctr, Seattle; Swedish Cancer Inst, Seattle;

N. Hanna, 2006 .

A further word of caution before using the internal mammary artery for coronary revascularization in patients with severe peripheral vascular disease!

K. Kent, A. Pichard, L. Satler, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Endovascular recanalization of central venous access to allow for pacemaker implantation or upgrade.

K. Kent, A. Pichard, L. Satler, 2012, Cardiovascular revascularization medicine : including molecular interventions.

A novel percutaneous coronary intervention risk score to predict one-year mortality.

A. Pichard, L. Satler, S. Collins, 2010, The American journal of cardiology.

Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

CRT-700.33 Transcatheter Aortic Valve Replacement in Low-Risk Patients With Bicuspid vs. Tricuspid Aortic Stenosis – 2-Year Follow-Up

M. Buchbinder, L. Satler, F. Asch, 2022, JACC: Cardiovascular Interventions.

Cellular video-phone assisted transmission and interpretation of prehospital 12-lead electrocardiogram in acute st-segment elevation myocardial infarction.

A. Pichard, L. Satler, R. Torguson, 2011, Journal of interventional cardiology.

Reliability of Prehospital Real-Time Cellular Video Phone in Assessing the Simplified National Institutes of Health Stroke Scale in Patients With Acute Stroke: A Novel Telemedicine Technology

Ron Waksman, L. Satler, R. Waksman, 2011, Stroke.

Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Longterm survival in a randomized studyRoselli M, Mariotti S, Ferroni P, et al (Policlinico Tor Vergata Univ, Rome; IRCCS san Raffaele, Rome) Int J Cancer 119:955–960, 2006§

N. Hanna, 2007 .

Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19

R. Hyzy, E. Leifer, J. López-Sendón, 2023, JAMA network open.

Synergistic increase risk of death and myocardial infarction at one year in patients with concomitant diabetes mellitus and renal failure

A. Pichard, L. Satler, S. Collins, 2010 .

Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes

M. Buchbinder, L. Satler, F. Asch, 2023, Circulation. Cardiovascular interventions.

EGFR Mutation and Resistance of Non-Small-Cell Lung Cancer to GefitinibKobayashi S, Boggon TJ, Dayaram T, et al (Harvard Med School, Boston; Univ Hosps of Cleveland, Ohio) N Engl J Med 352:786-792, 2005§

N. Hanna, 2006 .

Restaging patients with N2 (stage IIIa) non–small cell lung cancer after neoadjuvant chemoradiotherapy: A prospective studyCerfolio RJ, Bryant AS, Ojha B (Univ of Alabama at Birmingham) J Thorac Cardiovasc Surg 131:1229–1235, 2006§

N. Hanna, 2007 .

Does on‐ versus off‐hours presentation impact in‐hospital outcomes of ST‐segment elevation myocardial infarction patients transferred to a tertiary care center?

A. Pichard, L. Satler, S. Collins, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study

Cheng Soon Ong, Mohammad Hossein Khosravi, Muhammad Abubakar Siddique, 2021, The Journal of Thoracic and Cardiovascular Surgery.

Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin As Treatment for Chemotherapy-Naive Patients With Extensive-Disease Small-Cell Lung CancerEckardt JR, von Pawel J, Papai Z, et al (Ctr for Cancer Care and Research, St Louis; Zentralkra

N. Hanna, 2007 .

Self-expanding and balloon-expandable valves in low risk TAVR patients.

L. Satler, P. Parikh, Paul M. Gordon, 2023, International journal of cardiology.

Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.

Sara K. Rostanski, P. Teirstein, J. Bavaria, 2022, JAMA cardiology.